SCHEMBL7363440

SCHEMBL7363440

CC(C)(C)OC(=O)[C@H](Cc1ccccc1)NS(=O)(=O)c1ccc2c(NC(N)=NCl)cncc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
PLG P00747 3/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
F10 P00742 1/20 0.38
HPN P05981 1/20 0.38
CASP3 P42574 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BACE1 P56817 1/20 0.37
CTSL P07711 1/20 0.37
CTSS P25774 1/20 0.37
MMP2 P08253 4/20 0.37
MMP9 P14780 3/20 0.37
ADAMTS4 O75173 1/20 0.37
F2 P00734 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370338 0.88 PLAU (0.34) ALDH1A1PLGF10HPNF2
SCHEMBL7368832 0.88 F2 (0.40) POLBALDH1A1MAPTPLGF10
SCHEMBL7365021 0.87 MMP2 (0.36) PLGMEN1KMT2AMMP2MMP9
SCHEMBL7366260 0.85 PLAU (0.39) POLBALDH1A1MAPTPLGMEN1
SCHEMBL6432708 0.83 POLB (0.40) POLBALDH1A1MAPTPLGITGA4
SCHEMBL7374876 0.81 PLAU (0.46) MMP2MMP9ADAMTS4
SCHEMBL7050306 0.79 PLAU (0.37) ALDH1A1MAPTPLGF2SMN1; SMN2
SCHEMBL7374993 0.79 PLAU (0.42) POLBALDH1A1MAPTPLGMEN1
Hydrochloric Acid SCHEMBL7369278 0.78 PLAU (0.36) POLBPLGMEN1KMT2AMMP2
SCHEMBL7049646 0.78 PLAU (0.43) ALDH1A1MAPTMMP2MMP9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed
EP-1077945-A1 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2001-02-28 EP disclosed
WO-2000005214-A2 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2000-02-03 WO disclosed